These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 16678209)
41. [Cognitive impairment in the early phase of multiple sclerosis and its relationship with mood, demographic and clinical variables]. Nieto Barco A; Sánchez López Mdel P; Barroso Ribal J; Olivares Pérez T; Hernández Pérez MA Psicothema; 2008 Nov; 20(4):583-8. PubMed ID: 18940054 [TBL] [Abstract][Full Text] [Related]
42. Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study. Flechter S; Vardi J; Finkelstein Y; Pollak L Isr Med Assoc J; 2007 Jun; 9(6):457-9. PubMed ID: 17642394 [TBL] [Abstract][Full Text] [Related]
43. A longitudinal fMRI study of the paced auditory serial addition task. Cardinal KS; Wilson SM; Giesser BS; Drain AE; Sicotte NL Mult Scler; 2008 May; 14(4):465-71. PubMed ID: 18208900 [TBL] [Abstract][Full Text] [Related]
44. [Depression and frontal dysfunction: risks for the elderly?]. Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373 [TBL] [Abstract][Full Text] [Related]
45. [Neuropsychology of primary progressive multiple sclerosis]. Paes RA; Alvarenga RM; Vasconcelos CC; Negreiros MA; Landeira-Fernández J Rev Neurol; 2009 Oct 1-15; 49(7):343-8. PubMed ID: 19774527 [TBL] [Abstract][Full Text] [Related]
46. [Schizophrenic disorders--does cognitive dysfunction relate to characteristics of course and psychopathology of the illness?]. Wciórka J; Bembenek A; Hintze B; Kühn-Dymecka A Psychiatr Pol; 2006; 40(5):867-84. PubMed ID: 17217232 [TBL] [Abstract][Full Text] [Related]
47. The brief neuropsychological battery for children: a screening tool for cognitive impairment in childhood and juvenile multiple sclerosis. Portaccio E; Goretti B; Lori S; Zipoli V; Centorrino S; Ghezzi A; Patti F; Bianchi V; Comi G; Trojano M; Amato MP; Mult Scler; 2009 May; 15(5):620-6. PubMed ID: 19318511 [TBL] [Abstract][Full Text] [Related]
49. Cognitive dysfunction in multiple sclerosis: methods and prevalence from the GEDMA Study. Olazarán J; Cruz I; Benito-León J; Morales JM; Duque P; Rivera-Navarro J Eur Neurol; 2009; 61(2):87-93. PubMed ID: 19039226 [TBL] [Abstract][Full Text] [Related]
50. Mild cognitive impairment in symptomatic and asymptomatic cerebrovascular disease. Popović IM; Serić V; Demarin V J Neurol Sci; 2007 Jun; 257(1-2):185-93. PubMed ID: 17328916 [TBL] [Abstract][Full Text] [Related]
51. A neuropsychological assessment of frontal cognitive functions in Prader-Willi syndrome. Jauregi J; Arias C; Vegas O; Alén F; Martinez S; Copet P; Thuilleaux D J Intellect Disabil Res; 2007 May; 51(Pt 5):350-65. PubMed ID: 17391252 [TBL] [Abstract][Full Text] [Related]
52. Cognitive and psychosocial features of childhood and juvenile MS. Amato MP; Goretti B; Ghezzi A; Lori S; Zipoli V; Portaccio E; Moiola L; Falautano M; De Caro MF; Lopez M; Patti F; Vecchio R; Pozzilli C; Bianchi V; Roscio M; Comi G; Trojano M; Neurology; 2008 May; 70(20):1891-7. PubMed ID: 18474844 [TBL] [Abstract][Full Text] [Related]
53. Self- and informant reports of executive function on the BRIEF-A in MCI and older adults with cognitive complaints. Rabin LA; Roth RM; Isquith PK; Wishart HA; Nutter-Upham KE; Pare N; Flashman LA; Saykin AJ Arch Clin Neuropsychol; 2006 Oct; 21(7):721-32. PubMed ID: 16979868 [TBL] [Abstract][Full Text] [Related]
54. [Measuring the cognitive deficit associated with schizophrenia: presentation of the MATRICS neuropsychological test battery]. Sarolta K; Pál C; István B Neuropsychopharmacol Hung; 2007 Oct; 9(3):143-50. PubMed ID: 18399033 [TBL] [Abstract][Full Text] [Related]
55. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Tabert MH; Manly JJ; Liu X; Pelton GH; Rosenblum S; Jacobs M; Zamora D; Goodkind M; Bell K; Stern Y; Devanand DP Arch Gen Psychiatry; 2006 Aug; 63(8):916-24. PubMed ID: 16894068 [TBL] [Abstract][Full Text] [Related]
56. [From psychometry to neuropsychological disability in multiple sclerosis: a new brief French cognitive screening battery and cognitive risk factors]. Sartori E; Belliard S; Chevrier C; Trebon P; Chaperon J; Edan G Rev Neurol (Paris); 2006 May; 162(5):603-15. PubMed ID: 16710126 [TBL] [Abstract][Full Text] [Related]
57. Cognitive functioning in children with multiple sclerosis. Montiel-Nava C; Peña JA; González-Pernía S; Mora-La Cruz E Mult Scler; 2009 Feb; 15(2):266-8. PubMed ID: 18922833 [TBL] [Abstract][Full Text] [Related]
58. Cross cultural validation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Dusankova JB; Kalincik T; Havrdova E; Benedict RH Clin Neuropsychol; 2012; 26(7):1186-200. PubMed ID: 23034066 [TBL] [Abstract][Full Text] [Related]
59. [Cognitive impact of mitoxantrone and methylprednisolone in multiple sclerosis: an open label study]. Zéphir H; de Sèze J; Dujardin K; Dubois G; Cabaret M; Bouillaguet S; Ferriby D; Stojkovic T; Vermersch P Rev Neurol (Paris); 2008 Jan; 164(1):47-52. PubMed ID: 18342057 [TBL] [Abstract][Full Text] [Related]
60. Effects of using same- versus alternate-form memory tests during short-interval repeated assessments in multiple sclerosis. Benedict RH J Int Neuropsychol Soc; 2005 Oct; 11(6):727-36. PubMed ID: 16248908 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]